Anders Vik

2.3k total citations
78 papers, 1.8k citations indexed

About

Anders Vik is a scholar working on Molecular Biology, Biochemistry and Organic Chemistry. According to data from OpenAlex, Anders Vik has authored 78 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 22 papers in Biochemistry and 20 papers in Organic Chemistry. Recurrent topics in Anders Vik's work include Eicosanoids and Hypertension Pharmacology (20 papers), Fatty Acid Research and Health (16 papers) and Bone Metabolism and Diseases (12 papers). Anders Vik is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (20 papers), Fatty Acid Research and Health (16 papers) and Bone Metabolism and Diseases (12 papers). Anders Vik collaborates with scholars based in Norway, United States and United Kingdom. Anders Vik's co-authors include Trond Vidar Hansen, Lise‐Lotte Gundersen, Jesmond Dalli, Charles N. Serhan, John‐Bjarne Hansen, Ellisiv B. Mathiesen, Jørn E. Tungen, Jan Brox, Inger Njølstad and Marius Aursnes and has published in prestigious journals such as Blood, PLoS ONE and The Journal of Organic Chemistry.

In The Last Decade

Anders Vik

76 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Vik Norway 26 606 375 365 335 210 78 1.8k
Shugo Suzuki Japan 32 1.1k 1.8× 90 0.2× 197 0.5× 46 0.1× 177 0.8× 141 2.6k
Graham P. Pidgeon Ireland 29 1.0k 1.7× 91 0.2× 80 0.2× 273 0.8× 456 2.2× 65 2.7k
Imad Shureiqi United States 34 1.7k 2.8× 161 0.4× 193 0.5× 422 1.3× 404 1.9× 80 3.6k
B Jacotot France 27 485 0.8× 136 0.4× 498 1.4× 171 0.5× 1.0k 4.9× 124 2.2k
Saralyn Lindsey United States 19 624 1.0× 119 0.3× 426 1.2× 133 0.4× 630 3.0× 22 2.0k
Manfred Steiner United States 21 472 0.8× 96 0.3× 192 0.5× 101 0.3× 188 0.9× 59 1.9k
Setsuro Fujii Japan 23 1.1k 1.9× 126 0.3× 140 0.4× 142 0.4× 564 2.7× 119 2.8k
S. Colli Italy 28 545 0.9× 86 0.2× 648 1.8× 273 0.8× 857 4.1× 104 2.7k
Altaf Mohammed United States 27 888 1.5× 93 0.2× 115 0.3× 120 0.4× 246 1.2× 96 1.9k
Katsuya Endo Japan 29 796 1.3× 173 0.5× 40 0.1× 72 0.2× 359 1.7× 128 2.2k

Countries citing papers authored by Anders Vik

Since Specialization
Citations

This map shows the geographic impact of Anders Vik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Vik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Vik more than expected).

Fields of papers citing papers by Anders Vik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Vik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Vik. The network helps show where Anders Vik may publish in the future.

Co-authorship network of co-authors of Anders Vik

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Vik. A scholar is included among the top collaborators of Anders Vik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Vik. Anders Vik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mishra, Abhishek, et al.. (2025). Synthetic Epoxyeicosatrienoic Acid Mimics Protect Mesangial Cells from Sorafenib-Induced Cell Death. Molecules. 30(7). 1445–1445.
3.
Lee, Dae‐Weon, et al.. (2024). EpOME mediates the immune resolution and its alkoxide analog enhances the virulence of microbial insecticides against the legume pod borer, Maruca vitrata. Pesticide Biochemistry and Physiology. 205. 106155–106155. 1 indexed citations
4.
5.
Ghanima, Waleed, et al.. (2020). D-dimer as a stand-alone test to rule out deep vein thrombosis. Thrombosis Research. 191. 134–139. 19 indexed citations
6.
Sæther, Thomas, Steinar M. Paulsen, Jørn E. Tungen, et al.. (2018). Synthesis and biological evaluations of marine oxohexadecenoic acids: PPARα/γ dual agonism and anti-diabetic target gene effects. European Journal of Medicinal Chemistry. 155. 736–753. 15 indexed citations
7.
Souza, Patricia R., Roberta De Matteis, Shani Austin‐Williams, et al.. (2018). PDn-3 DPA Pathway Regulates Human Monocyte Differentiation and Macrophage Function. Cell chemical biology. 25(6). 749–760.e9. 48 indexed citations
8.
Vik, Anders, Jesmond Dalli, & Trond Vidar Hansen. (2017). Recent advances in the chemistry and biology of anti-inflammatory and specialized pro-resolving mediators biosynthesized from n-3 docosapentaenoic acid. Bioorganic & Medicinal Chemistry Letters. 27(11). 2259–2266. 57 indexed citations
9.
Hald, Erin Mathiesen, Ellen Brodin, Inger Njølstad, et al.. (2017). Myocardial infarction and future risk of cancer in the general population—the Tromsø Study. European Journal of Epidemiology. 32(3). 193–201. 59 indexed citations
10.
Njølstad, Inger, Ellisiv B. Mathiesen, Tom Wilsgaard, et al.. (2016). Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study. Journal of Thrombosis and Haemostasis. 14(6). 1183–1191. 42 indexed citations
11.
Vik, Anders, Ellen Brodin, Ellisiv B. Mathiesen, et al.. (2016). Serum osteoprotegerin and renal function in the general population: the Tromsø Study. Clinical Kidney Journal. 10(1). sfw095–sfw095. 5 indexed citations
12.
Stenstrøm, Yngve, et al.. (2016). Synthesis of 5-(S)-HETE, 5-(S)-HEPE and (+)-zooxanthellactone: Three hydroxylated polyunsaturated fatty acid metabolites. Chemistry and Physics of Lipids. 196. 1–4. 7 indexed citations
13.
Vik, Anders, Tove Skjelbakken, Jan Brox, et al.. (2015). Red cell distribution width and carotid atherosclerosis progression The Tromsø Study. Thrombosis and Haemostasis. 113(3). 649–654. 33 indexed citations
14.
Vik, Anders, Ellen Brodin, Ellisiv B. Mathiesen, et al.. (2014). Serum osteoprotegerin and future risk of cancer and cancer-related mortality in the general population: the Tromsø study. European Journal of Epidemiology. 30(3). 219–230. 18 indexed citations
15.
16.
Besada, Emilio, Anders Vik, Wenche Koldingsnes, & Johannes C. Nossent. (2013). Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review. International Journal of Hematology. 97(6). 800–803. 18 indexed citations
17.
Brodin, Ellen, Sigrid K. Brækkan, Anders Vik, Jan Brox, & John‐Bjarne Hansen. (2012). Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function - the Tromso study. Haematologica. 97(7). 1008–1013. 7 indexed citations
18.
Jørgensen, Lone, John‐Bjarne Hansen, Jan Brox, et al.. (2011). Serum osteoprotegerin levels are related to height loss: The Tromsø Study. European Journal of Epidemiology. 26(4). 305–312. 10 indexed citations
19.
Vik, Anders, Ellisiv B. Mathiesen, Stein Harald Johnsen, et al.. (2010). Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population – the Tromsø study. Journal of Thrombosis and Haemostasis. 8(5). 898–905. 32 indexed citations
20.
Jørgensen, Lone, Anders Vik, Nina Emaus, et al.. (2009). Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-κB ligand: the Tromsø Study. Osteoporosis International. 21(6). 931–938. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shugo Suzuki Breakdown of academic impact, for papers by Graham P. Pidgeon Breakdown of academic impact, for papers by Imad Shureiqi Breakdown of academic impact, for papers by B Jacotot Breakdown of academic impact, for papers by Saralyn Lindsey Breakdown of academic impact, for papers by Manfred Steiner Breakdown of academic impact, for papers by Setsuro Fujii Breakdown of academic impact, for papers by S. Colli Breakdown of academic impact, for papers by Altaf Mohammed Breakdown of academic impact, for papers by Katsuya Endo
Rankless by CCL
2026